Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

792
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
792
Population Growth00:57

Population Growth

28.4K
Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.4K
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

254
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
254
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

216
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
216
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

349
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
349
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

305
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
305

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postacute COVID-19 Symptoms and Health Care Utilization and Spending Among Traditional Medicare Beneficiaries.

JAMA network open·2026
Same author

Making Policy When the Perfect Is Impossible.

JAMA health forum·2026
Same author

Atomic-Level Synergy of Dual Single-Atom Catalysts for Photocatalytic Hydrogen Evolution Reaction.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Comparative toxicity of nickel titanate and calcium manganite perovskite nanomaterials in human and bacterial systems: Implications for environmental and health risks.

Chemosphere·2026
Same author

Ni-Catalyzed Synthesis of Trisubstituted Hydrazones via Cascade Dehydrogenative Coupling of Alcohol.

The Journal of organic chemistry·2026
Same author

A Plasmon-Driven Transparent and Flexible Microsupercapacitor for Dual Solar-Hydrovoltaic Energy Harvesting.

Nano letters·2026

Related Experiment Video

Updated: Jan 29, 2026

Evaluating the Function of the Foot Core System in the Elderly
08:25

Evaluating the Function of the Foot Core System in the Elderly

Published on: March 11, 2022

3.3K

Explaining The Slowdown In Medical Spending Growth Among The Elderly, 1999-2012.

David M Cutler1, Kaushik Ghosh2, Kassandra L Messer3

  • 1David M. Cutler ( dcutler@harvard.edu ) is the Otto Eckstein Professor of Applied Economics in the Department of Economics at Harvard University and a research associate at the National Bureau of Economic Research, both in Cambridge, Massachusetts.

Health Affairs (Project Hope)
|February 5, 2019
PubMed
Summary
This summary is machine-generated.

Medicare spending growth slowed due to reduced spending on cardiovascular diseases and other conditions. Medications significantly reduced cardiovascular events, highlighting opportunities for further cost savings through prevention.

More Related Videos

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

13.2K
In Situ Visualization of Axon Growth and Growth Cone Dynamics in Acute Ex Vivo Embryonic Brain Slice Cultures
10:45

In Situ Visualization of Axon Growth and Growth Cone Dynamics in Acute Ex Vivo Embryonic Brain Slice Cultures

Published on: October 14, 2021

4.1K

Related Experiment Videos

Last Updated: Jan 29, 2026

Evaluating the Function of the Foot Core System in the Elderly
08:25

Evaluating the Function of the Foot Core System in the Elderly

Published on: March 11, 2022

3.3K
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

13.2K
In Situ Visualization of Axon Growth and Growth Cone Dynamics in Acute Ex Vivo Embryonic Brain Slice Cultures
10:45

In Situ Visualization of Axon Growth and Growth Cone Dynamics in Acute Ex Vivo Embryonic Brain Slice Cultures

Published on: October 14, 2021

4.1K

Area of Science:

  • Health Economics
  • Geriatric Medicine
  • Cardiovascular Research

Background:

  • Per capita spending for Medicare beneficiaries (ages 65+) in the U.S. showed a declining growth trend after 2005.
  • Understanding the drivers of this spending slowdown is crucial for healthcare policy and resource allocation.

Purpose of the Study:

  • To analyze trends in per capita Medicare spending for beneficiaries aged 65+ from 1999-2012.
  • To identify the specific conditions contributing to the observed decline in spending growth.

Main Methods:

  • Decomposition analysis of per capita spending by medical condition.
  • Review of medical literature to estimate the impact of pharmaceuticals on acute disease and cardiovascular events.

Main Results:

  • Slower spending growth for cardiovascular diseases accounted for approximately half of the overall spending slowdown.
  • Reduced spending growth was also observed for dementia, renal and genitourinary diseases, and aftercare for acute illnesses.
  • Pharmaceuticals controlling cardiovascular risk factors were linked to roughly half of the reduction in major cardiovascular events, indicating significant cost savings.

Conclusions:

  • The decline in Medicare spending growth is substantially influenced by reduced spending in key areas like cardiovascular diseases.
  • Pharmaceutical interventions have demonstrably improved cardiovascular health and reduced healthcare costs.
  • Further opportunities exist to lower healthcare spending through enhanced disease prevention and management strategies.